# BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma

> **NCT03794167** · PHASE2 · COMPLETED · sponsor: **Soonchunhyang University Hospital** · enrollment: 75 (actual)

## Conditions studied

- Non-hodgkin Lymphoma

## Interventions

- **DRUG:** Busulfan
- **DRUG:** Cyclophosphamide
- **DRUG:** Etoposide
- **DRUG:** Melphalan

## Key facts

- **NCT ID:** NCT03794167
- **Lead sponsor:** Soonchunhyang University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06-01
- **Primary completion:** 2017-05-30
- **Final completion:** 2018-11-30
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2019-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03794167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03794167, "BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03794167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*